LAHJOITA! AJANKOHTAISTA BLOGIT RINNEKOTI 90v OTA YHTEYTTÄ ANNA PALAUTETTA

Alkuperäisjulkaisut

2015

Bjelogric-Laakso N, Vuorinen E. Hoitolinjaukset osaksi kehitysvammaisten potilaiden hyvää arkea. Suomen Lääkärilehti 48/2015, 3267-3268.

Heikkilä K., Vuoksimaa E., Saari-Kemppainen A., Kaprio J., Rose R. J., Haukka J., Pitkäniemi J., Iivanainen M.(2015) Higher prevalence of left-handedness in twins? Not after controlling birth time confounders. Twin Research and Human Genetics  18: 5: 526-532.

Iivanainen M. Ensimmäisenä neurologina epilepsiasairaalassa. Lääkäri ja Vapaa-aika -lehti 32: 1: 30–33, 2015.

Kaipainen P, Westermarck T, Atroshi F, Kaski M, Iivanainen M. Clinical and Hematological Profiles During Valproate Treatment of Epileptic Patients with Intellectual Disability — Case Study and Mini Review. In: "Pharmacology and Nutritional Intervention in the Treatment of Disease" (Atroshi, F, editor),INTECH Publisher, ISBN 978-953-51-1383-6. May 28, 2014 under CC BY 3.0 license 2014, 273-281.

Karhumaa H-M, Höglund P, Nuutinen O. Monivammaisen kehitysvammaisen aikuisen ravitsemuksessa on parannettavaa. Suomen Lääkärilehti 48/2015, 3273-3280.

Płonka-Półtorak E, Westermarck T, Kaipainen P, Kaski M and Atroshi F. Trace Elements, Antioxidant Enzymes and Free Carnitine Levels among Epileptic Patients Treated with Valproate Monotherapy. In: ”Pharmacology and Nutritional Intervention in the Treatment of Disease” (Atroshi, F, editor),INTECH Publisher, ISBN 978-953-51-1383-6. May 28, 2014 under CC BY 3.0 license 2014, 265-271.

Rantanen E. Jotta arkielämä ja sairaus saataisiin paremmin yhteen. Julkisen ja kolmannen sektorin yhteistyö harvinaisissa sairauksissa. Rinnekoti-Säätiö, Norio-keskus.

Tikkanen R., Tiihonen J., Rautiainen MR., Paunio T., Bevilacqua L., Panarsky R., Goldman D., Virkkunen M. (2015) Impulsive alcohol-related risk-behavior and emotional dysregulation among individuals with a serotonin 2 B receptor stop codon. Translational Psychiatry 5, e681; doi:10.1038/tp.2015.170.

2014

Arvio M., Bjelogrlic-Laakso N., Salokivi T. (2014) Cannabinoid mouth spray brought help to a severely spastic young man. Duodecim 130, 1452-4.

Bjelogric-Laakso N., Aaltonen S., Dorn T., Arvio M. (2014) Need for special units for the management of neuropsychiatric disorders in people with intellectual disabilities. Acta Psychiatr Scand 130, 77-9.

Hiltunen S., Virta M., Salakari A., Antila M., Chydenius E., Kaski M., Vataja R., Iivanainen M., Partinen M. (2014) Better long-term outcome for hypnotherapy than for CBT in adults with ADHD: results of a six-month follow-up. Contemporary Hypnosis and Integrtive Therapy 30, 118-34.

Westerinen H., Kaski M., Virta L.J., Almqvist F., Iivanainen M. (2014) Age-specific prevalence of intellectual disability in Finland at the beginning of new millennium-multiple register method. Journal of Intellectual Disability Research 58, 285-95.

2013

Jansson LC, Louhivuori L, Wigren HK, Nordström T, Louhivuori V, Castrén ML, Åkerman KE.Effect of gluta-mate receptor antagonists on migrating neural progenitor cells. Eur J Neurosci. 2013 May;37(9):1369-82.

Louhivuori LM, Louhivuori V, Wigren HK, Hakala E, Jansson LC, Nordström T, Castrén ML, Akerman KE. Role of low voltage activated calcium channels in neuritogenesis and active migration of embryonic neural progenitor cells. Stem Cells Dev. 2013 Apr 15;22(8):1206-19.

Płonka-Półtorak E, Zagrodzki P, Nicol F, Kryczyk J, Bartoń H, Westermarck T, Kaipainen P, Ounjaijean S, Kaski M, Atroshi F. Antioxidant agents and physiological responses in adult epileptic patients treated with lamotrigine. Pharmacol Rep. 2013;65(1):99-106. (T)

Stoll G, Pietiläinen OP, Linder B, Suvisaari J, Brosi C, Hennah W, Leppä V, Torniainen M, Ripatti S, Ala-Mello S ym. Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat Neurosci. 2013 Sep;16(9):1228-37.

Westerinen H, Kaski M, Virta LJ, Almqvist F, Iivanainen M. Age-specific prevalence of intellectual disability in Finland at the beginning of new millennium – multiple register method. J Intellect Disabil Res. (painossa)

2012

Jansson L, Henna-Kaisa Wigren H-K, Tommy Nordström T, Lauri Louhivuori L, Louhivuori V, Castrén ML, Åkerman KE. BDNF increases the motility of a particular NMDA/GABA-responsive subset of neural progenitor cells. Neuroscience 2012;224:223-34 (T).

Kaipainen P, Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PloS one Epub 2012 Mar 28.

Niskanen E, Könönen M, Villberg V, Nissi M, Ranta-Aho P, Säisänen L, Karjalainen P, Äikiä M, Kälviäinen R, Mervaala E, Vanninen R. The effect of fMRI task combinations on determing the hemispheric dominance of language functions. Neuroradiology 2012;54(4):393-405.

Paavola LE, Remes AM, Sonninen PH, Kiviniemi VV, Korhonen TT, Majamaa K. An Unusual Developmental Profile of Salla Disease in a Patient with the Salla FIN Mutation. Case Rep Neurol Med Epub 2012 Nov 22.

Raatikainen E, Bjelogrlic-Laakso N. Tuloksekas hypnoterapia kehitysvammaisen potilaan vaikeahoitoisessa epilepsiassa. Duodecim 2012; 128:978-80.

Uutela M, Lindholm J, Louhivuori V, Wei H, Louhivuori LM, Pertovaara A, Åkerman K, Castrén E, Castrén ML. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits. Genes Brain Behav 2012;5:513-523 (T).

2011

Gürakan F, Baysoy G, Wedenoja S, Uslu N, Ozen H, Ozaltin F, Höglund P. Three cases of a rare disease, congenital chloride diarrhea, summons up the variation in the clinical course and significance of early diagnosis and adequate treatment in prevention of intellectual disability. Turk J Pediatr 2011; 53(2):194-8.

Heikkilä K, Vuoksimaa E, Oksava K, Saari-Kemppainen A, Iivanainen M. Handedness in the Helsinki ultrasound trial. Ultrasound in Obstetrics and Gynecology 2011; 37:638-642. 2011. (T)

Kantojärvi K, Kotala I, Rehnström K, Ylisaukko-Oja T, Vanhala R, von Wendt TN, von Wendt L, Järvelä I. Fine mapping of Xq11.1-q21.33 and mutation screening of RPS6KA6, ZNF711, ACSL4, DLG3, and IL1RAPL2 for autism spectrum disorders (ASD) Autism Res. 2011; 4(3):228-33. (T)

Louhivuori V, Vicario A, Uutela M, Rantamäki T, Louhivuori L.M, Castén E, Tongiorgi E, Åkerman K.E, Castrén M.L. BDNF and TrkB in neuronal differentiation of Fmr1-knockput mouse. Neurobiology of Disease 2011; 41:469-480. (T)

Määttä T, Määttä J, Tervo-Määttä T, Taanila A, Kaski M, Iivanainen M. Healthcare and guidelines: A population-based survey of recorded medical problems and health surveillance for people with Down syndrome. Journal of Intellectual and Developmental Disability 2011; 36:118-126.

Niskanen E, Könönen M, Villberg V. Nissi M, Ranta-Aho P, Säisänen L, Karjalainen P, Aikiä M, Kälviäinen R, Mervaala E, Vanninen R.The effect of fMRI task combinations on determining the hemispheric dominance of language functions. Neuroradiology. Epub 2011 Sep 20.

Ounjaijean S, Westermarck T, Partinen M, Plonka-Poltorak E, Kaipainen P, Kaski M, Fucharoen S, Srichairatanakool S, Atrochi F. Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. Int J Clin Pharmacol Ther 2011; 49(4):268-76. (T)

Plonka-Póltorak E, Zagrodzki P, Chlopicka J, Bartón H, Westermarck T, Kaipainen P, Kaski M, Atroshi F. Valproic Acid Modulates Superoxide Dismutase, Uric Acid-Intependent FRAP and Adult Epileptic Patients. Biol Trace Elem Res 2011; 143:1424-1434. (T)